EN
Search for:
Navigation
Services
Preclinical
Clinical
Biotesting
Regulatory
Home
About us
The company
The executive team
The facilities
Our partners
Certifications
Jobs
News & Events
News & Publications
Events
Testimonials
FAQ
Contact
News & Events
>
News & Publications
>
Clinical study on Covid-19 - End of recruitment
Published on 02/12/2021
Clinical study on Covid-19 - End of recruitment
📣 Artialis is pleased to announce the end of recruitment of its first clinical study on COVID-19 (CHOPIN with Nasafytol). In this comparative randomized clinical trial, patients received NASAFYTOL (curcumin and quercetin) as a nutritional support to the standard treatment of hospitalized patients infected with COVID-19.
âž¡ More information on
ClinicalTrials.gov
Identifier : NCT04844658
We thank the Sponsor for its trust toward Artialis’ services.
Artialis, a leader CRO located in Belgium has demonstrated that it can ensure fast recruitment in infectious disease.
Our latest news
11/05/2023
Heeft u artrose van de knie?
03/05/2023
Klinisch onderzoek naar spierzwakte
Read more
News & Publications
Events
Testimonials
© Artialis - All rights reserved
Cookie Notice
-
Privacy Policy
Made by